For its second fiscal quarter (ending June 30), PacWest Bancorp (NYSE: PACW) has reported E.P.S. of $0.12 compared to $-1.75 a year ago. This performance was $-0.09 short of the consensus estimate of $0.21. For […]
Freeport-McMoRan Inc (NYSE: FCX) has reported E.P.S. of $0.42 for its second fiscal quarter (ending June 30) versus $0.24 for the same period a year ago — an increase of 75%. Relative to the consensus […]
First Financial Corp/IN (NASDAQ: THFF) has reported earnings for its second fiscal quarter (ending June 30) of $0.96 versus $1.33 for the same period a year ago — a decline of -28%. This result fell […]
First Busey Corp (NASDAQ: BUSE) has reported earnings for its second fiscal quarter (ending June 30) of $0.48 versus $0.53 for the same period a year ago — a decline of -9%. This result fell […]
FS Bancorp Inc (NASDAQ: FSBW) has reported E.P.S. of $1.15 for its second fiscal quarter (ending June 30) versus $1.17 for the same period a year ago — a decline of -2%. Relative to the […]
For its second fiscal quarter (ending June 30), Veritex Holdings Inc (NASDAQ: VBTX) has reported a -19% decline in E.P.S. from $0.62 a year ago to $0.50 in the current quarter. This result fell short […]
Renasant Corp (NYSE: RNST) has reported earnings for its second fiscal quarter (ending June 30) of $0.69 versus $0.51 for the same period a year ago — an increase of 35%. This result exceeded the […]
Orrstown Financial Services Inc (NASDAQ: ORRF) has reported earnings for its second fiscal quarter (ending June 30) of $0.74 versus $0.95 for the same period a year ago — a decline of -22%. However, this […]
For its second fiscal quarter (ending June 30), Alphabet Inc (NASDAQ: GOOGL) has reported a 32% increase in E.P.S. from $1.45 a year ago to $1.91 in the current quarter. This result exceeded the consensus […]
Kimberly-Clark Corp (NYSE: KMB) has reported E.P.S. of $1.61 for its second fiscal quarter (ending June 30) versus $0.30 for the same period a year ago — an increase of 437%. However, this result fell […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research